375 related articles for article (PubMed ID: 20395365)
21. HEXIM1 is an essential transcription regulator during human erythropoiesis.
Lv X; Murphy K; Murphy Z; Getman M; Rahman N; Nakamura Y; Blanc L; Gallagher PG; Palis J; Mohandas N; Steiner LA
Blood; 2023 Dec; 142(25):2198-2215. PubMed ID: 37738561
[TBL] [Abstract][Full Text] [Related]
22. Structural Insights into the DNA-Binding Mechanism of BCL11A: The Integral Role of ZnF6.
Viennet T; Yin M; Jayaraj A; Kim W; Sun ZJ; Fujiwara Y; Zhang K; Seruggia D; Seo HS; Dhe-Paganon S; Orkin SH; Arthanari H
bioRxiv; 2024 Jan; ():. PubMed ID: 38293057
[TBL] [Abstract][Full Text] [Related]
23. Evolution of nanobodies specific for BCL11A.
Yin M; Izadi M; Tenglin K; Viennet T; Zhai L; Zheng G; Arthanari H; Dassama LMK; Orkin SH
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2218959120. PubMed ID: 36626555
[TBL] [Abstract][Full Text] [Related]
24. The glucocorticoid receptor elicited proliferative response in human erythropoiesis is BCL11A-dependent.
Mazzarini M; Cherone J; Nguyen T; Martelli F; Varricchio L; Funnell APW; Papayannopoulou T; Migliaccio AR
bioRxiv; 2024 Feb; ():. PubMed ID: 38370646
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic and kinetic insights into Transcription factor biology via acute protein depletion.
Mehta S; Buyanbat A; Kai Y; Orkin SH
Exp Hematol; 2024 Jun; ():104250. PubMed ID: 38862078
[TBL] [Abstract][Full Text] [Related]
26. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.
Xu J; Bauer DE; Kerenyi MA; Vo TD; Hou S; Hsu YJ; Yao H; Trowbridge JJ; Mandel G; Orkin SH
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6518-23. PubMed ID: 23576758
[TBL] [Abstract][Full Text] [Related]
27. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.
Bauer DE; Kamran SC; Lessard S; Xu J; Fujiwara Y; Lin C; Shao Z; Canver MC; Smith EC; Pinello L; Sabo PJ; Vierstra J; Voit RA; Yuan GC; Porteus MH; Stamatoyannopoulos JA; Lettre G; Orkin SH
Science; 2013 Oct; 342(6155):253-7. PubMed ID: 24115442
[TBL] [Abstract][Full Text] [Related]
28. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
[TBL] [Abstract][Full Text] [Related]
29. KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.
Zhou D; Liu K; Sun CW; Pawlik KM; Townes TM
Nat Genet; 2010 Sep; 42(9):742-4. PubMed ID: 20676097
[TBL] [Abstract][Full Text] [Related]
30. Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus.
Jawaid K; Wahlberg K; Thein SL; Best S
Blood Cells Mol Dis; 2010 Aug; 45(2):140-6. PubMed ID: 20542454
[TBL] [Abstract][Full Text] [Related]
31. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis.
Xu J; Shao Z; Glass K; Bauer DE; Pinello L; Van Handel B; Hou S; Stamatoyannopoulos JA; Mikkola HK; Yuan GC; Orkin SH
Dev Cell; 2012 Oct; 23(4):796-811. PubMed ID: 23041383
[TBL] [Abstract][Full Text] [Related]
32. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
Bauer DE; Orkin SH
Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
[TBL] [Abstract][Full Text] [Related]
33. Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
Liu N; Hargreaves VV; Zhu Q; Kurland JV; Hong J; Kim W; Sher F; Macias-Trevino C; Rogers JM; Kurita R; Nakamura Y; Yuan GC; Bauer DE; Xu J; Bulyk ML; Orkin SH
Cell; 2018 Apr; 173(2):430-442.e17. PubMed ID: 29606353
[TBL] [Abstract][Full Text] [Related]
34. The switch from fetal to adult hemoglobin.
Sankaran VG; Orkin SH
Cold Spring Harb Perspect Med; 2013 Jan; 3(1):a011643. PubMed ID: 23209159
[TBL] [Abstract][Full Text] [Related]
35. Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.
Bauer DE; Kamran SC; Orkin SH
Blood; 2012 Oct; 120(15):2945-53. PubMed ID: 22904296
[TBL] [Abstract][Full Text] [Related]
36. BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations.
Basak A; Hancarova M; Ulirsch JC; Balci TB; Trkova M; Pelisek M; Vlckova M; Muzikova K; Cermak J; Trka J; Dyment DA; Orkin SH; Daly MJ; Sedlacek Z; Sankaran VG
J Clin Invest; 2015 Jun; 125(6):2363-8. PubMed ID: 25938782
[TBL] [Abstract][Full Text] [Related]
37. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin.
Borg J; Papadopoulos P; Georgitsi M; Gutiérrez L; Grech G; Fanis P; Phylactides M; Verkerk AJ; van der Spek PJ; Scerri CA; Cassar W; Galdies R; van Ijcken W; Ozgür Z; Gillemans N; Hou J; Bugeja M; Grosveld FG; von Lindern M; Felice AE; Patrinos GP; Philipsen S
Nat Genet; 2010 Sep; 42(9):801-5. PubMed ID: 20676099
[TBL] [Abstract][Full Text] [Related]
38. A functional element necessary for fetal hemoglobin silencing.
Sankaran VG; Xu J; Byron R; Greisman HA; Fisher C; Weatherall DJ; Sabath DE; Groudine M; Orkin SH; Premawardhena A; Bender MA
N Engl J Med; 2011 Sep; 365(9):807-14. PubMed ID: 21879898
[TBL] [Abstract][Full Text] [Related]
39. Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin.
Masuda T; Wang X; Maeda M; Canver MC; Sher F; Funnell AP; Fisher C; Suciu M; Martyn GE; Norton LJ; Zhu C; Kurita R; Nakamura Y; Xu J; Higgs DR; Crossley M; Bauer DE; Orkin SH; Kharchenko PV; Maeda T
Science; 2016 Jan; 351(6270):285-9. PubMed ID: 26816381
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic regulation of fetal globin gene expression in adult erythroid cells.
Ginder GD
Transl Res; 2015 Jan; 165(1):115-25. PubMed ID: 24880147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
